Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafenoquine for Vivax Malaria in Papua New Guinean Children
NCT07403643Phase 4Not yet recruiting
- Sponsor
- Curtin University
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafenoquine in malaria, sponsored by Curtin University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
tafenoquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07403643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07403643.